Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Validation of the logistic clinical syntax (synergy between percutaneous coronary interventions with taxus and cardiac surgery) score

JACC: Cardiovascular Interventions

Volumn 6, Issue 7, 2013, Pages 737-745

  Farooq, Vasim ^a   Vergouwe, Yvonne ^a   Généreux, Philippe ^b   Bourantas, Christos V ^a   Palmerini, Tullio ^b   Caixeta, Adriano ^b   Garcìa Garcìa, Hector M ^a   Diletti, Roberto ^a   Morel, Marie Angèle ^c   McAndrew, Thomas C ^b   Kappetein, Arie Pieter ^a   Valgimigli, Marco ^d   Windecker, Stephan ^e   Dawkins, Keith D ^f   Steyerberg, Ewout W ^a   Serruys, Patrick W ^a   Stone, Gregg W ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NewYork Presbyterian Hospital   (United States)

^c CARDIALYSIS   (Netherlands)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY OF BERN   (Switzerland)

^f BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

acute coronary syndrome; drug eluting stents; mortality; predictions; SYNTAX score; validation

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BARE METAL STENT; CALIBRATION; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG ELUTING STENT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYNTAX SCORE;

ACS; ACUTE CORONARY SYNDROME; ACUTE CORONARY SYNDROMES; BARE-METAL STENT(S); BMS; CRCL; CREATININE CLEARANCE; DES; DRUG-ELUTING STENT(S); DRUG-ELUTING STENTS; INTERQUARTILE RANGE(S); IQR; LEFT VENTRICULAR EJECTION FRACTION; LVEF; MORTALITY; PCI; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PREDICTIONS; PVD; SYNTAX SCORE; VALIDATION;

ACUTE CORONARY SYNDROME; AGED; CORONARY ANGIOGRAPHY; DECISION SUPPORT TECHNIQUES; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880303240     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.04.004     Document Type: Article

References (42)

1. SYNTAX Working Group. SYNTAX score calculator. [Online tool]. May 19, 2009. Available at: http://www.syntaxscore.com. Accessed November 1, 2012.
2. P.W.erruys, M.C. Morice, A.P. Kappetein SYNT Investigators Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
3. P.W. Serruys, Y. Onuma, and S. Garg Assessment of the SYNTAX score in the Syntax study EuroIntervention 5 2009 50 56
4. G. Sianos, M.A. Morel, and A.P. Kappetein The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227
5. A.P. Kappetein, T.E. Feldman, and M.J. Mack Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
6. S. Garg, G. Sarno, and C. Girasis A patient-level pooled analysis assessing the impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials J Am Coll Cardiol Intv 4 2011 645 653
7. V. Farooq, S. Brugaletta, and P.W. Serruys Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention Heart 97 2011 1902 1913
8. T. Palmerini, P. Genereux, and A. Caixeta Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial J Am Coll Cardiol 57 2011 2389 2397
9. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
10. W. Wijns, P. Kolh, N. Danchin Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
11. V. Farooq, P.W. Serruys, G.W. Stone, R. Virmani, A. Chieffo, and J. Fajadet Left main coronary artery disease E. Eeckhout, P.W. Serruys, W. Wijns, A. Vahanian, M. van Sambeek, R. de Palma, Percutaneous Interventional Cardiovascular Medicine: The PCR-EAPCI Textbook. Part III, Chapter 12 2012 PCR Publishing/Europa Edition Toulouse, France 329 405
12. P.W. Serruys, V. Farooq, and P. Vranckx A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX trial at 3 years J Am Coll Cardiol Intv 5 2012 606 617
13. V. Farooq, Y. Vergouwe, and L. Räber Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score Eur Heart J 33 2012 3098 3104
14. G.W. Stone, M. Bertrand, and A. Colombo Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial: study design and rationale Am Heart J 148 2004 764 775
15. J. Aoki, A.J. Lansky, and R. Mehran Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 119 2009 687 698
16. P. Genereux, T. Palmerini, and A. Caixeta SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements Circ Cardiovasc Interv 4 2011 553 561
17. M. Valgimigli, G. Percoco, P. Malagutti STRATEGY Investigators Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial JAMA 293 2005 2109 2117 (Pubitemid 40617063)
18. P.W. Serruys, A.T. Ong, and M.C. Morice Arterial Revascularisation Therapies Study Part II: sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions EuroIntervention 1 2005 147 156
19. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662 (Pubitemid 41175673)
20. S. Windecker, P.W. Serruys, and S. Wandel Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Lancet 372 2008 1163 1173
21. M. Valgimigli, G. Campo, G. Percoco MULTISTRATEGY Investigators Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA 299 2008 1788 1799 (Pubitemid 351549970)
22. P.W. Serruys, S. Silber, and S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
23. E.W. Steyerberg Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating 2009 Springer New York, NY
24. R Development Core Team. A language and environment for statistical computing. 2006. Available at: http://www.R-project.org/. Accessed August 1, 2011.
25. F.E. Harrell Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer Series in Statistics 2001 Springer New York, NY
26. E.W. Steyerberg, A.J. Vickers, and N.R. Cook Assessing the performance of prediction models: a framework for traditional and novel measures Epidemiology 21 2010 128 138
27. A.J. Vickers, and E.B. Elkin Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 2006 565 574 (Pubitemid 44728772)
28. A.R. Localio, and S. Goodman Beyond the usual prediction accuracy metrics: reporting results for clinical decision making Ann Intern Med 157 2012 294 295
29. E.W. Steyerberg, and A.J. Vickers Decision curve analysis: a discussion Med Decis Making 28 2008 146 149
30. E.M. Antman, M. Cohen, and P.J. Bernink The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 2000 835 842 (Pubitemid 30643610)
31. P. Royston, M.K. Parmar, and R. Sylvester Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer Stat Med 23 2004 907 926 (Pubitemid 38344230)
32. N.R. Cook Use and misuse of the receiver operating characteristic curve in risk prediction Circulation 115 2007 928 935 (Pubitemid 46294733)
33. M.S. Pepe, H. Janes, and J.W. Gu Letter by Pepe et al. regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction." Circulation 116 2007 e132 author reply e134
34. M.E. Farkouh, M. Domanski, L.A. Sleeper FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
35. M. Tonelli, P. Muntner, A. Lloyd Alberta Kidney Disease Network Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study Lancet 380 2012 807 814
36. C.S. Fox, K. Matsushita, M. Woodward Chronic Kidney Disease Diagnosis Prognosis Consortium Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis Lancet 380 2012 1662 1673
37. V Farooq, D. van Klaveren, and E.W. Steyerberg Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381 2013 639 650
38. T. Palmerini, G. Biondi-Zoccai, and D. Della Riva Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
39. S. Bangalore, S. Kumar, and M. Fusaro Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117,762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
40. D. Alexopoulos, A. Galati, and I. Xanthopoulou Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study J Am Coll Cardiol 60 2012 193 199
41. S.P. de Boer, M.J. Lenzen, and R.M. Oemrawsingh Evaluating the "all-comers" design: a comparison of participants in two "all-comers" PCI trials with non-participants Eur Heart J 32 2011 2161 2167
42. C.W. Nam, F. Mangiacapra, R. Entjes FAME Study Investigators Functional SYNTAX score for risk assessment in multivessel coronary artery disease J Am Coll Cardiol 58 2011 1211 1218